Cite
Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax.
MLA
Matulis, S. M., et al. “Dexamethasone Treatment Promotes Bcl-2 Dependence in Multiple Myeloma Resulting in Sensitivity to Venetoclax.” Leukemia, vol. 30, no. 5, May 2016, pp. 1086–93. EBSCOhost, https://doi.org/10.1038/leu.2015.350.
APA
Matulis, S. M., Gupta, V. A., Nooka, A. K., Hollen, H. V., Kaufman, J. L., Lonial, S., & Boise, L. H. (2016). Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax. Leukemia, 30(5), 1086–1093. https://doi.org/10.1038/leu.2015.350
Chicago
Matulis, S M, V A Gupta, A K Nooka, H V Hollen, J L Kaufman, S Lonial, and L H Boise. 2016. “Dexamethasone Treatment Promotes Bcl-2 Dependence in Multiple Myeloma Resulting in Sensitivity to Venetoclax.” Leukemia 30 (5): 1086–93. doi:10.1038/leu.2015.350.